Human Genome Epidemiology Literature Finder
|
Records 1 - 22 (of 22 Records) |
| Query Trace: Carcinoma and CYP3A4[original query] |
|---|
| CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. International journal of cancer. Journal international du cancer 2003 Apr 104 (3): 310-7. Silvestri Laura, Sonzogni Laura, De Silvestri Annalisa, Gritti Chiara, Foti Luciana, Zavaglia Claudio, Leveri Michela, Cividini Agostino, Mondelli Mario U, Civardi Emilio, Silini Enrico |
| Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa. Pharmacogenetics 2004 Oct 14 (10): 691-700. Wojnowski Leszek, Turner Paul C, Pedersen Bonnie, Hustert Elisabeth, Brockmöller Jürgen, Mendy Maimuna, Whittle Hilton C, Kirk Greg, Wild Christopher |
| Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Sep 14 (9): 2183-90. Starr Jacqueline R, Chen Chu, Doody David R, Hsu Li, Ricks Sherianne, Weiss Noel S, Schwartz Stephen |
| Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer. British journal of clinical pharmacology 2005 Apr 59 (4): 415-24. Zhou Qingyu, Sparreboom Alex, Tan Eng-Huat, Cheung Yin-Bun, Lee Ann, Poon Donald, Lee Edmund J D, Chowbay Balr |
| Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers. International journal of clinical oncology 2007 Aug 12 (4): 284-90. Jiko Mari, Yano Ikuko, Sato Eriko, Takahashi Kazushige, Motohashi Hideyuki, Masuda Satohiro, Okuda Masahiro, Ito Noriyuki, Nakamura Eijiro, Segawa Takehiko, Kamoto Toshiyuki, Ogawa Osamu, Inui Ken-Ic |
| Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Cancer genetics and cytogenetics 2010 Jan 196 (1): 76-82. Tai Jun, Yang Ming, Ni Xin, Yu Dianke, Fang Jugao, Tan Wen, Huang Zhigang, Wu Chen, Chen Xiaohong, Wang Guanghai, Zhou Weiguo, Chen Xuejun, Zhang Wei, Ma Lijing, Lin Dongxin, Han Dem |
| Evaluation of the influence of polymorphic variants CYP1A1 2B, CYP1B1 2, CYP3A4 1B, GSTM1 0, and GSTT1 0 in prostate cancer. Urologic oncology 0 29 (6): 654-63. Rodrigues Iara S, Kuasne Hellen, Losi-Guembarovski Roberta, Fuganti Paulo E, Gregório Emerson P, Kishima Marina O, Ito Kazuhiro, de Freitas Rodrigues Marco A, de Syllos Cólus Ilce |
| The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients. Cancer chemotherapy and pharmacology 2011 Jun 67 (6): 1471-8. Chew Sin-Chi, Singh Onkar, Chen Xiangai, Ramasamy Rathi Devi, Kulkarni Tejal, Lee Edmund J D, Tan Eng-Huat, Lim Wan-Teck, Chowbay Balr |
| Study the polymorphism of CYP3A5 and CYP3A4 loci in Iranian population with laryngeal squamous cell carcinoma. Molecular biology reports 2011 Nov 38 (8): 5443-8. Azarpira Negar, Ashraf Mohamad Javad, Khademi Bigan, Darai Masumeh, Hakimzadeh Afsoon, Abedi Elh |
| Population pharmacokinetic analysis of sorafenib in patients with solid tumours. British journal of clinical pharmacology 2011 Aug 72 (2): 294-305. Jain Lokesh, Woo Sukyung, Gardner Erin R, Dahut William L, Kohn Elise C, Kummar Shivaani, Mould Diane R, Giaccone Giuseppe, Yarchoan Robert, Venitz Jürgen, Figg William |
| Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study. The Lancet. Oncology 2011 Nov 12 (12): 1143-50. Garcia-Donas Jesus, Esteban Emilio, Leandro-García Luis Javier, Castellano Daniel E, del Alba Aranzazu González, Climent Miguel Angel, Arranz José Angel, Gallardo Enrique, Puente Javier, Bellmunt Joaquim, Mellado Begoña, Martínez Esther, Moreno Fernando, Font Albert, Robledo Mercedes, Rodríguez-Antona Cristi |
| Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Feb 35 (2): 1671-8. Islam Mohammad Safiqul, Mostofa A G M, Ahmed Maizbha Uddin, Bin Sayeed Muhammad Shahdaat, Hassan Md Rajib, Hasnat Ab |
| Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma. European journal of clinical pharmacology 2015 Sep . Diekstra Meta H M, Liu Xiaoyan, Swen Jesse J, Boven Epie, Castellano Daniel, Gelderblom Hans, Mathijssen Ron H J, Rodríguez-Antona Cristina, García-Donas Jesus, Rini Brian I, Guchelaar Henk-J |
| Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma. Oncotarget 2016 May . Zhou Jun, Wen Qiang, Li Sai-Fei, Zhang Yun-Fei, Gao Na, Tian Xin, Fang Yan, Gao Jie, Cui Ming-Zhu, He Xiao-Pei, Jia Lin-Jing, Jin Han, Qiao Hai-Li |
| SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma. Pharmacogenomics 2016 Mar . Duran Ignacio, Hagen Carlos, Arranz José Ángel, Apellaniz-Ruiz María, Pérez-Valderrama Begoña, Sala Nuria, Lainez Nuria, García-Del Muro Xavier, Noguerón Esther, Climent Miguel Ángel, Maroto Pablo, Font Albert, García-Donas Jesús, Gallardo Enrique, López-Criado Pilar, González Del Alba Aránzazu, Sáez María Isabel, Vázquez Sergio, Luque Raquel, Rodríguez-Antona Cristi |
| Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma. The pharmacogenomics journal 2016 Jan . Diekstra M H, Belaustegui A, Swen J J, Boven E, Castellano D, Gelderblom H, Mathijssen R H, García-Donas J, Rodríguez-Antona C, Rini B I, Guchelaar H |
| Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer. Cancer chemotherapy and pharmacology 2017 Jul . Mbatchi Litaty C, Gassiot Matthieu, Pourquier Philippe, Goberna Alejando, Mahammedi Hakim, Mourey Loic, Joly Florence, Lumbroso Serge, Evrard Alexandre, Houede Nadi |
| Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma. European urology focus 2016 Dec 2 (6): 633-639. de Velasco Guillermo, Gray Kathryn P, Hamieh Lana, Urun Yuksel, Carol Hallie A, Fay Andre P, Signoretti Sabina, Kwiatkowski David J, McDermott David F, Freedman Matthew, Pomerantz Mark M, Choueiri Toni |
| The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China. Oncotarget 2017 Mar . Bai Xianan, Xie Jingjing, Sun Shanshan, Zhang Xianyu, Jiang Yongdong, Pang |
| Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma. Pharmacogenomics 2019 12 20 (18): 1283-1290. Goey Andrew Kl, With Mirjam de, Agema Bram C, Hoop Esther Oomen-De, Singh Rajbir K, van der Veldt Astrid Am, Mathijssen Ron Hj, van Schaik Ron Hn, Bins Sand |
| Establishment of predicting equation for individual sufentanil dosage postoperatively based on gene polymorphisms. Pain practice : the official journal of World Institute of Pain 2021 5 22 (1): 39-46. Cheng Huawei, Zeng Rong, Kong Lingsuo, Ding Conglan, He Yifu, Zhuang Wei, Sun Yanc |
| The Effects of Cumulative Dose and Polymorphisms in CYP2B6 on the Mitotane Plasma Trough Concentrations in Chinese Patients With Advanced Adrenocortical Carcinoma. Frontiers in oncology 2022 12 919027. Liu Xin, Shang Junmei, Fu Qiang, Lu Lin, Deng Jianhua, Tang Yan, Li Jiantao, Mei Dan, Zhang Bo, Zhang Shuya |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: